BIONIME (4737.TW) monthly revenue, September 2026

BIONIME reported revenue of NT$0.18bn for September 2026, up 20.0% from the previous month and up 20.9% from a year earlier. Year-to-date revenue was NT$1.31bn, down 7.4% year on year. It ranked 54 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.1820.020.9